Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 2Anatomic Stage IV Breast Cancer AJCC v8 2Oligo-metastatic Prostate Carcinoma 1Lymphoma, Follicular 1Dementia 1Cognitive Dysfunction 1Brain Neoplasms 1Anxiety Disorders 1Anomia 1Anatomic Stage I Breast Cancer AJCC v8 1Alzheimer Disease 1

Interventions

XENP 1595 2Electroencephalography 2mazdutide 1enzalutamide 1amlodipine, atorvastatin drug combination 1UE2343 1Tomography, X-Ray Computed 1Tomography, Emission-Computed 1Tablets 1Standard of Care 1Referral and Consultation 1Prednisone 1Positron-Emission Tomography 1Methotrexate 1Methods 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hormones 1Gonadotropin-Releasing Hormone 1Exercise 1Ethanol 1Drug Delivery Systems 1Dignity Therapy 1Decision Support Techniques 1Atorvastatin 1Aging 1Activities of Daily Living 1Accidental Falls 1Abiraterone Acetate 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dementia × Hormones × Clear all
NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed
73 enrolled
Lymphoid

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡